$1.64 -0.06 (-3.53%)
2/10/2012 3:59 PM

Aeterna Zentaris, Inc. (USA) (NASDAQ:AEZS)

CAPS Rating: 5 out of 5

A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.

Featured Broker Partners


Advertisement